NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









cureVision

cureVision

Private
MunichHealthcare & Life Scienceshttps://curevision.de/

Last Round

Seed

Oct 7, 2025

Est. Valuation

$12.64M

Total Funding Raised

$4.09M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

cureVision is a medical technology company that provides an AI-powered, all-in-one solution for the digital analysis, documentation, and management of chronic wounds.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

wound care AIdigital wound managementautomated wound assessment3D wound analysischronic wound managementmedical deviceMDR certifiedmedical computer vision3D wound imagingwound documentation softwarecontactless wound measurementEHR integrationHIS integrationhandheld medical devicemedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

cureVision Comparables

Compare cureVision with similar companies based on industry and business-model similarity.

cureVision comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

cureVision Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 7, 2025
AcceleratorMar 28, 2024
GrantMar 23, 2023
SeedOct 18, 2022

cureVision Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    Grew 17% QoQ, from 23 to 27 employees.

  • Jan 1, 2026

    Monthly visitors increased 65% MoM, reaching 1.2K.

cureVision Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

cureVision Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about cureVision's valuation, stock price, and market status.

Firmographic Details

HeadquartersMunich
Employee Range25
Year Founded2021
Last FundingOct 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.